| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $4,230,491 ) |
| | 2025 | 2025 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | UM1AI069511 | University of Rochester HIV/AIDS Clinical Trials Unit | 000 | 19 | NIH | 11/14/2024 | $782,393 |
| | 2025 | 2025 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R01AR082324 | High throughput isotropic resolution fluorescence and second Harmonic imaging to characterize tendon injury | 000 | 2 | NIH | 11/14/2024 | $426,926 |
| | 2025 | 2025 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R01ES034829 | Endocrine Disrupting Chemicals and Male-biased Neurobehavioral Disorders | 000 | 3 | NIH | 11/14/2024 | $336,242 |
| | 2025 | 2025 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R01NS131967 | Non-Invasive Multi-Modal Neuromonitoring in Adults Undergoing Extracorporeal Membrane Oxygenation | 000 | 2 | NIH | 11/15/2024 | $410,278 |
| | 2025 | 2025 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | UM1AI069511 | University of Rochester HIV/AIDS Clinical Trials Unit | 000 | 19 | NIH | 11/14/2024 | $126,299 |
| | 2025 | 2025 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | K23ES032459 | Effect of Air Pollution on the Immune Response to Respiratory Viral Infection in Adults | 000 | 5 | NIH | 11/15/2024 | $236,438 |
| | 2025 | 2025 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R01MH131532 | Using novel virtual reality tasks to identify neural mechanisms of discrimination learning in PTSD | 000 | 3 | NIH | 11/1/2024 | $602,764 |
| | 2025 | 2025 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R01DC010813 | Developing and Testing Models of the Auditory System With and Without Hearing Loss | 000 | 15 | NIH | 11/4/2024 | $380,406 |
| | 2025 | 2025 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | K99GM152790 | Regulation of exon junction complex composition and assembly | 000 | 2 | NIH | 11/4/2024 | $125,000 |
| | 2025 | 2025 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R01AI175212 | Role of T-bet B cells in rheumatoid arthritis | 000 | 2 | NIH | 10/29/2024 | $683,909 |
| | 2025 | 2024 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R35GM133462 | Molecular mechanisms of RNA-targeting CRISPR-Cas systems and their membrane-associated accessory proteins | 000 | 6 | NIH | 11/6/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R35GM144001 | Molecular Mechanisms and Evolution of Phenotypic Plasticity | 000 | 3 | NIH | 11/6/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | F31NS129099 | Effects of Intracortical Microstimulation on Neural Activity in Distant Cortical Regions | 000 | 3 | NIH | 11/14/2024 | -$48,897 |
| | 2025 | 2024 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R01MH131738 | Effectiveness Trial of Wingman-Connect Implemented Across Career Phases | 000 | 2 | NIH | 11/13/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R35GM148349 | Biological Sex as a Modulator of Neuronal Development and Function | 000 | 2 | NIH | 11/11/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R35GM149420 | Molecular mechanisms of the core and linker histone tail domains that drive chromatin condensation | 000 | 2 | NIH | 11/14/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R01DC017519 | Behavioral and physiological consequences of auditory nerve loss | 001 | 6 | NIH | 11/1/2024 | $5,510 |
| | 2025 | 2024 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R01DC017519 | Behavioral and physiological consequences of auditory nerve loss | 001 | 6 | NIH | 11/1/2024 | $1,056 |
| | 2025 | 2024 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | K01AG084878 | Competence, Autonomy, Relatedness, and Connections (CARe Connections): A Peer-Led Intervention Designed with Parkinsons Disease & Related Disorders Carepartners to Improve Holistic Support | 000 | 1 | NIH | 11/5/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R35GM119515 | The evolutionary and functional genomics of satellite DNA | 000 | 8 | NIH | 11/7/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R35GM149268 | Nonsense-mediated mRNA decay and beyond | 000 | 2 | NIH | 11/5/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | T32AI007285 | The T32 Predoctoral Training Program in Immunology (PTPI) | 000 | 37 | NIH | 10/10/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | G5953710 | Rural Northern Border Region Outreach Program | 01 | 1 | HRSA | 10/2/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | NU65PS923777 | Capacity Building Assistance (CBA) for HIV Prevention Programs to End the HIV Epidemic in the United States | 02 | 1 | CDC | 10/29/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | P50HD103536 | University of Rochester Intellectual and Developmental Disabilities Research Center | 000 | 5 | NIH | 10/15/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | NU01DD000017 | Pregnant People-Infant Linked Analysis to Understand Outcomes Associated with Substance UseDisorders During Pregnancy | 01 | 2 | CDC | 10/17/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | NU01DD000017 | Pregnant People-Infant Linked Analysis to Understand Outcomes Associated with Substance UseDisorders During Pregnancy | 01 | 2 | CDC | 10/17/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R35GM145283 | RNA Structure Modeling Using Physics and Sequence Comparison | 000 | 3 | NIH | 11/8/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | T3442125 | Primary Care Training and Enhancement-Community Prevention and Maternal Health | 01 | 4 | HRSA | 11/5/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | UD933632 | The Regional Centers of Excellence in Substance Use Disorder Education Program | 01 | 3 | HRSA | 10/18/2024 | $0 |
| | 2025 | 2023 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | K99AG071736 | Targeting H4K20 methylation to rejuvenate aged stem cell epigenome and regenerative function. | 000 | 2 | NIH | 10/30/2024 | -$1,851 |
| | 2025 | 2023 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R01DC017519 | Behavioral and physiological consequences of auditory nerve loss | 002 | 5 | NIH | 11/1/2024 | -$1,056 |
| | 2025 | 2023 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R01DC017519 | Behavioral and physiological consequences of auditory nerve loss | 000 | 5 | NIH | 11/1/2024 | -$5,510 |
| | 2025 | 2023 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R01DK124619 | Role of Hypothalamic MC4R in Glucose Homeostasis via a Novel Neuroendocrine Circuit involving the Kidneys and Adrenal Glands | 001 | 3 | NIH | 10/22/2024 | -$147,075 |
| | 2025 | 2023 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R01DK124619 | Role of Hypothalamic MC4R in Glucose Homeostasis via a Novel Neuroendocrine Circuit involving the Kidneys and Adrenal Glands | 000 | 3 | NIH | 10/22/2024 | -$162,163 |
| | 2025 | 2023 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R21AI166114 | In vivo persistence and immuno-pathogenesis of Mycobacterium abscessus in a new Xenopus tadpole model | 000 | 2 | NIH | 10/29/2024 | $0 |
| | 2025 | 2023 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R01DE027686 | New craniofacial bone engineering through miR-23-27-24 cluster mediated osteogenic angiogenic coupling | 003 | 5 | NIH | 10/16/2024 | $469,613 |
| | 2025 | 2023 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | F31DE030670 | Elucidating the Mechanisms of Salivary Gland Dysfunction Following Gamma-Irradiation Utilizing an Experimental and Computational Approach | 000 | 3 | NIH | 10/23/2024 | -$18,826 |
| | 2025 | 2023 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R21CA267040 | Re-designing anti-CD20 monoclonal antibody therapy using novel insights into limitations of innate immune cytotoxicity | 000 | 2 | NIH | 10/17/2024 | $0 |
| | 2025 | 2023 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | NU01DD000017 | Pregnant People-Infant Linked Analysis to Understand Outcomes Associated with Substance UseDisorders During Pregnancy | 01 | 2 | CDC | 10/17/2024 | $0 |
| | 2025 | 2023 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | CE152383 | Community Project Funding/Congressionally Directed Spending - Construction | 05 | 1 | HRSA | 10/22/2024 | $0 |
| | 2025 | 2022 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R21DA057500 | G alpha Z subunit as a potential therapeutic target to modulate mu opioid receptor pharmacology | 000 | 1 | NIH | 10/30/2024 | $0 |
| | 2025 | 2022 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R01NR017892 | Peer Approaches to Lupus Self-Management (PALS) | 000 | 6 | NIH | 11/12/2024 | -$306,083 |
| | 2025 | 2022 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R01GM125839 | Epithelial Cell Reintegration in Development and Disease | 000 | 5 | NIH | 10/22/2024 | -$26,364 |
| | 2025 | 2022 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R21MH127486 | The impact of early life stress on the immature primate amygdala: influence on mental health trajectories | 000 | 2 | NIH | 10/22/2024 | $0 |
| | 2025 | 2022 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R21ES032159 | Exosomal epigenetic biomarkers associated with flavored electronic cigarette usein adults | 000 | 2 | NIH | 10/23/2024 | -$145 |
| | 2025 | 2021 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R01DE019463 | Small Molecule Microenvironment Design for Craniofacial Bone Regeneration and Engineering | 003 | 8 | NIH | 10/21/2024 | $361,627 |
| | 2025 | 2020 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | RF1AG063811 | Factors associated with hospitalization, ICU use and death among vulnerable populations diagnosed with COVID-19 | 000 | 1 | NIH | 10/31/2024 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $203,834,006 ) (Continued on the next page) |
|
